Trial intelligence / Profile preview

Metoclopramide vs Erythromycin for Gastric Residual Volume in ICU Patients

IRCT20240929063203N8Phase 3Recruiting

Sponsor
Hormozgan University of Medical Sciences
Start
Jun 2026
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in gastroparesis comparing Metoclopramide arm with Erythromycin arm (2 arms). Started Jun 2026; status: recruiting.

02

Drugs

metoclopramideerythromycin
03

Conditions

gastroparesis

Beyond the preview

Go deeper on IRCT20240929063203N8.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240929063203N8.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call